Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
IDEXX Laboratories Analyst Ratings
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520
IDEXX Laboratories Analyst Ratings
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620
IDEXX Laboratories Analyst Ratings
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating
IDEXX Laboratories Analyst Ratings
Piper Sandler Downgrades Idexx to Neutral, Cites Macro Headwinds
IDEXX Laboratories Analyst Ratings
IDEXX Laboratories Analyst Ratings
Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
IDEXX Laboratories Analyst Ratings
Barclays Maintains Overweight on IDEXX Laboratories, Raises Price Target to $592
IDEXX Laboratories Analyst Ratings
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $460
IDEXX Laboratories Analyst Ratings
Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $500
IDEXX Laboratories Analyst Ratings